Welcome to our dedicated page for Materialise news (Ticker: MTLS), a resource for investors and traders seeking the latest updates and insights on Materialise stock.
Materialise NV reports developments in additive manufacturing software, 3D printing services, and 3D-printed medical devices. The Belgium-based foreign issuer trades on Nasdaq through ADSs and has ordinary shares listed on Euronext Brussels. Company updates commonly cover operating and financial results, segment trends in Materialise Medical, Materialise Software, and Materialise Manufacturing, and the role of 3D printing solutions across healthcare, automotive, aerospace, eyewear, art and design, wearables, and consumer goods.
Recurring announcements also include earnings-call schedules, annual and extraordinary shareholder meeting actions, regulated information under Belgian market rules, voting-rights and share-count notices, and changes affecting specific activities within the company’s 3D printing portfolio.
Materialise (Nasdaq: MTLS) announced plans for an additional listing of its ordinary shares on Euronext Brussels and an ADS buyback program of up to EUR 30 million. The Euronext listing is expected on or around November 20, 2025 and will complement the existing Nasdaq ADS listing to broaden the investor base and provide liquidity and operational flexibility. The ADS buyback was approved by the board on October 27, 2025, may repurchase approximately 6.1 million ADSs based on the Oct 28, 2025 close, is subject to shareholder approval on November 14, 2025, and is expected to be initiated by no later than January 2026 with execution within 12 months.
Materialise (NASDAQ:MTLS) reported Q3 2025 results for the quarter ended September 30, 2025. Total revenue was 66,259 kEUR, down 3.5% year-over-year but up 2.2% from Q2 2025. Materialise Medical revenue set a quarterly record at 33,296 kEUR, +10.3% YoY. Adjusted EBIT was 2,918 kEUR (4.4% margin) and net profit was 1,848 kEUR (EUR 0.03 per diluted share). Cash and cash equivalents were 132,022 kEUR with gross debt of 64,278 kEUR, producing a net cash position of 67,744 kEUR (increase of 6,724 kEUR since Dec 31, 2024). Full-year 2025 revenue guidance remains 265,000–280,000 kEUR and Adjusted EBIT guidance unchanged at 6,000–10,000 kEUR.
Materialise (NASDAQ: MTLS) will report third quarter 2025 results for the period ended September 30, 2025 on Tuesday, October 28, 2025 at 6:30 a.m. ET / 11:30 a.m. CET. Senior management will host a conference call to discuss results on October 28, 2025 at 8:30 a.m. ET / 1:30 p.m. CET.
Investors can join the call by phone (dial-in details provided via the link at least 15 minutes before start time) or listen to a live audio webcast at http://investors.materialise.com. The webcast will be archived on the company website for later access.
Materialise (NASDAQ:MTLS), a leader in additive manufacturing and medical software, reported mixed Q2 2025 financial results. Total revenue decreased 5.8% to 64,831 kEUR, though the Medical segment grew 16.7%. Gross profit margin improved to 58.3% from 57.0% year-over-year.
The company's Adjusted EBIT improved to 3,058 kEUR from 646 kEUR in Q1 2025 but remained below Q2 2024's 3,872 kEUR. Net profit was 199 kEUR, significantly impacted by unfavorable exchange rates. The company maintains a strong balance sheet with 63,045 kEUR in net cash.
Due to geopolitical volatility and economic uncertainty, Materialise revised its 2025 revenue guidance to 265,000-280,000 kEUR but maintained its Adjusted EBIT guidance of 6,000-10,000 kEUR.
Materialise (NASDAQ: MTLS), a leader in additive manufacturing software and 3D printing services, has scheduled its Q2 2025 earnings release for July 24, 2025 at 6:30 a.m. ET.
The company will host a conference call with senior management to discuss the results at 8:30 a.m. ET on the same day. Participants can access the call through a dial-in option or receive a callback. Additionally, a live audio webcast will be available through the investor relations website, with an archived version accessible afterward.
Materialise (NASDAQ:MTLS), a leading additive manufacturing software and 3D printing solutions provider, has announced its upcoming Annual General Shareholders' Meeting (AGM) scheduled for June 3, 2025, at 10:00 am CET. The company will also hold an Extraordinary Shareholders' Meeting on the same date to vote on proposed amendments to its articles of association. The key proposals include:
- Renewal of Board of Directors' authorization to increase authorized share capital
- Modification of the statutory AGM date starting in 2026
All relevant documents, including the annual report and meeting notices, are accessible on the company's investor relations website.
Materialise (NASDAQ:MTLS) reported Q1 2025 financial results with total revenue increasing 4.3% to 66,379 kEUR, primarily driven by an 18.7% growth in the Medical segment. The company posted a net loss of (535) kEUR or (0.01) EUR per share, compared to a profit of 3,585 kEUR in Q1 2024.
Key metrics include:
- Medical segment revenue up 18.7% to 31,078 kEUR
- Software segment revenue down 6.4% to 9,775 kEUR
- Manufacturing segment revenue decreased 5.5% to 25,526 kEUR
- Adjusted EBIT declined to 646 kEUR from 2,656 kEUR year-over-year
- Net cash position improved by 6,716 kEUR to 67,736 kEUR
The company maintained its FY2025 guidance, expecting consolidated revenue between 270,000-285,000 kEUR and Adjusted EBIT of 6,000-10,000 kEUR, despite ongoing macro-economic and geo-political uncertainties.
Materialise NV (NASDAQ: MTLS), a leading provider of additive manufacturing software and sophisticated 3D printing services, has scheduled its first quarter 2025 earnings release for Thursday, April 24, 2025 at 6:30 a.m. ET/12:30 p.m. CET.
The company will host a conference call with senior management to discuss Q1 2025 financial results on the same day at 8:30 a.m. ET/2:30 p.m. CET. Participants can choose to dial in or receive a call to connect to the conference. Additionally, a live audio webcast will be available through the investor relations website and will be archived for future reference.
Materialise (NASDAQ:MTLS) reported its Q4 and full-year 2024 results, showing mixed performance across segments. Total revenue increased 0.6% to 65,680 kEUR in Q4 2024, driven by 14.3% growth in the Medical segment. Full-year 2024 revenue grew 4.2% to 266,765 kEUR.
The company's Medical segment continued strong performance with record-high revenues, while Manufacturing segment faced challenges from European industrial sector headwinds. Q4 Adjusted EBITDA decreased to 4,306 kEUR from 8,474 kEUR in 2023, while net profit improved to 2,907 kEUR (0.05 EUR per share) from a loss of 539 kEUR.
For 2025, Materialise expects consolidated revenues between 270,000-285,000 kEUR and Adjusted EBIT of 6,000-10,000 kEUR. The company maintains strong financials with cash reserves of 102,304 kEUR and reduced gross debt to 41,284 kEUR by end of 2024.
Materialise NV (NASDAQ: MTLS), a leading provider of additive manufacturing software and 3D printing services, has scheduled its fourth quarter 2024 earnings release for Thursday, February 20, 2025, at 6:30 a.m. ET/12:30 p.m. CET.
The company will host a conference call with senior management to discuss the financial results at 8:30 a.m. ET/2:30 p.m. CET on the same day. Participants can choose to dial in or receive a call through a registration link. Additionally, a live audio webcast will be available through the investor relations website and will be archived for future reference.